Arrail Group Secures $200 Million in Series E Funding

(VCBeat) Apr. 13, 2021 -- Arrail Group, a leading brand in dental service in China, today announced the close of a $200 million Series E investment round, led by Temasek with participation from OrbiMed, Ward Ferry, Hina Group, Industrial Bank and Mirae Asset Securities. CEC Capital continues to act as the exclusive financial adviser in this transaction, which is the fifth cooperation between CEC Capital and Arrail Group since 2010.

Founded in 1999, Arrail Group took the lead in introducing the advanced concept of foreign dental clinics into China. Now it has become the leading brand in the high-end dental service industry in China. Adhering to the service concept of "customer is family", Arrail Group is committed to bringing high-quality dental services in line with international standards to customers. 

At present, Arrail Group has two brands, Arrail Dental and Rytime Dental, driven by the dual-brand strategy, the group has completed the construction of more than 100 dental clinics and hospitals in 16 cities in China, serving nearly ten million customers in total. It has also signed agreements with a number of well-known companies.

Arrail Group has a perfect dental talent system. At present, it has brought together well-known oral health experts at home and abroad, mainly from the Royal College of Dentistry, University of London, West China School/Hospital of Stomatology Sichuan University, School of Stomatology Peking University, and other well-known universities at home and abroad. 

At the same time, Arrail Group has close cooperation with the University of Pennsylvania School of Stomatology, University of California Los Angeles School of Stomatology and other internationally renowned universities. In addition, through building its own online training platform and carrying out the online + offline training mode, the group has formed a mature doctor training mechanism.

The investment will enable Arrail Group to improve its own development strategy, actively build clinics across the country, and provide high-quality oral health services for China and even the world.

Incorporated in 1974, Temasek is an investment company based in Singapore. Temasek's portfolio covers a broad spectrum of sectors: telecommunications, media & technology; financial services; transportation & industrials; consumer & real estate; life sciences & agriculture; energy & resources. 

OrbiMed is a healthcare-dedicated investment firm, with approximately US$5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies.